Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

What To Expect From Bowhead Specialty’s (BOW) Q2 Earnings

August 03, 2025 at 23:21 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

BOW Cover Image

Specialty insurance company Bowhead Specialty Holdings (NYSE: BOW) will be announcing earnings results this Tuesday before market open. Here’s what investors should know.

Bowhead Specialty beat analysts’ revenue expectations by 1.8% last quarter, reporting revenues of $122.7 million, up 35.3% year on year. It was a mixed quarter for the company, with a slight miss of analysts’ net premiums earned estimates.

Is Bowhead Specialty a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Bowhead Specialty’s revenue to grow 32.5% year on year to $131 million, slowing from the 51.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.36 per share.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Bowhead Specialty has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time since going public by 3.2% on average.

Looking at Bowhead Specialty’s peers in the property & casualty insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Mercury General delivered year-on-year revenue growth of 13.2%, beating analysts’ expectations by 2%, and Allstate reported revenues up 6%, falling short of estimates by 0.7%. Mercury General’s stock price was unchanged after the resultswhile Allstate was up 5.7%.

Read our full analysis of Mercury General’s results here and Allstate’s results here.

Debates around the economy’s health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the property & casualty insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4% on average over the last month. Bowhead Specialty is down 8.3% during the same time and is heading into earnings with an average analyst price target of $42 (compared to the current share price of $31.92).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article